The Wonderful World of SGLT2 Inhibitors
Update on the newest treatments in the treatment of diabetes with SGLT2 medications.
At the conclusion of this activity, the attendee will be able to:
•Discuss the pathophysiology and pharmacology of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors
•Review evidence behind the use of SGLT2 in patients with Type 2 Diabetes
•List the potential benefits SGLT2 inhibitors in patients with Heart Failure and Renal disease
Anthony Gerber, PharmD
PGY-2 Ambulatory Care Pharmacy Resident
Long Island University/The Brooklyn Hospital Center
Telephone: (718) 250-8657
No conflicts of interest exist with this presenter.
- 1.00 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.